S100A6 - New facts and features

Biochemical and Biophysical Research Communications

Volumn 390, Issue 4, 2009, Pages 1087-1092

  Leśniak, Wiesława ^a   Słomnicki, Łukasz P ^a   Filipek, Anna ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

Extracellular function; Intracellular signaling; S100 proteins; S100A6 (calcyclin); Tumorigenesis

Indexed keywords

CALCYCLIN; PROTEIN S 100;

ACUTE GRANULOCYTIC LEUKEMIA; ANAPLASTIC CARCINOMA; ASTROCYTOMA; BILE DUCT CARCINOMA; BREAST CANCER; CELL ACTIVITY; CHOLESTEATOMA; CHRONIC MYELOID LEUKEMIA; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CRANIOPHARYNGIOMA; FOLLICULAR CARCINOMA; HUMAN; JUVENILE MELANOMA; LIVER CELL CARCINOMA; LIVER METASTASIS; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MEDULLOBLASTOMA; MELANOCYTIC NEVUS; MELANOMA; MENINGIOMA; MOUTH CARCINOMA; MOUTH SQUAMOUS CELL CARCINOMA; NEUROTHEKEOMA; NONHUMAN; NOSE POLYP; OSTEOSARCOMA; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS INVASIVE DUCTAL CARCINOMA; PANCREAS JUICE; PANCREATIC DUCTAL ADENOCARCINOMA; PANCREATIC INTRAEPITHELIAL NEOPLASIA; PAPILLARY CARCINOMA; PAPILLARY THYROID CARCINOMA; PATHOLOGY; PHENOTYPE; PILOMATRIXOMA; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; SALIVARY GLAND TUMOR; SHORT SURVEY; STOMACH CANCER; THYROID CARCINOMA;

ANIMALS; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MICE; NEOPLASMS; RABBITS; RATS; S100 PROTEINS;

AVES; MAMMALIA;

EID: 70450231669     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.10.150     Document Type: Short Survey

References (80)

1. Santamaria-Kisiel L., Rintala-Dempsey A.C., and Shaw G.S. Calcium-dependent and -independent interactions of the S100 protein family. Biochem. J. 396 (2006) 201-214
2. Schafer B.W., Wicki R., Engelkamp D., Mattei M.G., and Heizmann C.W. Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of S100 calcium binding protein family. Genomics 25 (1995) 638-643
3. Ridinger K., Ilg E.C., Niggli F.K., Heizmann C.W., and Schäfer B.W. Clustered organization of S100 genes in human and mouse. Biochim. Biophys. Acta 1448 (1998) 254-263
4. Allen B.G., Andrea J.E., Sutherland C., Schönekess B.O., and Walsh M.P. Molecular cloning of chicken calcyclin (S100A6) and identification of putative isoforms. Biochem. Cell Biol. 75 (1997) 733-738
5. Wojda U., and Kuźnicki J. Calcyclin from mouse Ehrlich ascites tumor cells and rabbit lung form non-covalent dimers. Biochim. Biophys. Acta 1209 (1994) 248-252
6. Potts B.C., Smith J., Akke M., Macke T.J., Okazaki K., Hidaka H., Case D.A., and Chazin W.J. The structure of calcyclin reveals a novel homodimeric fold for S100 Ca(2+)-binding proteins. Nat. Struct. Biol. 2 (1995) 790-796
7. Yang Q., O'Hanlon D., Heizmann C.W., and Marks A. Demonstration of heterodimer formation between S100B and S100A6 in the yeast two-hybrid system and human melanoma. Exp. Cell Res. 246 (1999) 501-509
8. Deloulme J.C., Assard N., Mbele G.O., Mangin C., Kuwano R., and Baudier J. S100A6 and S100A11 are specific targets of the calcium- and zinc-binding S100B protein in vivo. J. Biol. Chem. 275 (2000) 35302-35310
9. 2+-binding protein (10.5 kDa) from Ehrlich-ascites-tumour cells. Biochem. J. 247 (1987) 663-667
10. Kuźnicki J., Filipek A., Hunziker P.E., Huber S., and Heizmann C.W. Calcium-binding protein from mouse Ehrlich ascites-tumour cells is homologous to human calcyclin. Biochem. J. 263 (1989) 951-956
11. Sastry M., Ketchem R.R., Crescenzi O., Weber C., Lubienski M.J., Hidaka H., and Chazin W.J. The three-dimensional structure of Ca(2+)-bound calcyclin: implications for Ca(2+)-signal transduction by S100 proteins. Structure 6 (1998) 223-231
12. Filipek A., Heizmann C.W., and Kuźnicki J. Calcyclin is a calcium and zinc binding protein. FEBS Lett. 264 (1990) 263-266
13. Kuźnicki J., Kordowska J., Puzianowska M., and Woźniewicz B.M. Calcyclin as a marker of human epithelial cells and fibroblasts. Exp. Cell Res. 200 (1992) 425-430
14. Filipek A., Puzianowska M., Cieślak B., and Kuźnicki J. Calcyclin-Ca(2+)-binding protein homologous to glial S-100 beta is present in neurones. Neuroreport 4 (1993) 383-386
15. Yamashita N., Ilg E.C., Schäfer B.W., Heizmann C.W., and Kosaka T. Distribution of a specific calcium-binding protein of the S100 protein family, S100A6 (calcyclin), in subpopulations of neurons and glial cells of the adult rat nervous system. J. Comp. Neurol. 404 (1999) 235-257
16. Mandinova A., Atar D., Schäfer B.W., Spiess M., Aebi U., and Heizmann C.W. Distinct subcellular localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rises in intracellular calcium. J. Cell Sci. 111 (1998) 2043-2054
17. Engelkamp D., Schäfer B.W., Erne P., and Heizmann C.W. S100 alpha, CAPL, and CACY: molecular cloning and expression analysis of three calcium-binding proteins from human heart. Biochemistry 31 (1992) 10258-10264
18. Tomida Y., Terasawa M., Kobayashi R., and Hidaka H. Calcyclin and calvasculin exist in human platelets. Biochem. Biophys. Res. Commun. 189 (1992) 1310-1316
19. Ferrari S., Tagliafico E., Manfredini R., Grande A., Rossi E., Zucchini P., Torelli G., and Torelli U. Abundance of the primary transcript and its processed product of growth-related genes in normal and leukemic cells during proliferation and differentiation. Cancer Res. 52 (1992) 11-16
20. 2+-dependent interaction of calcyclin with membrane. Biochem. Biophys. Res. Commun. 220 (1996) 269-273
21. Stradal T.B., and Gimona M. Ca(2+)-dependent association of S100A6 (calcyclin) with the plasma membrane and the nuclear envelope. J. Biol. Chem. 274 (1999) 31593-31596
22. Orre L.M., Pernemalm M., Lengqvist J., Lewensohn R., and Lehtiö J. Up-regulation, modification, and translocation of S100A6 induced by exposure to ionizing radiation revealed by proteomics profiling. Mol. Cell. Proteomics 6 (2007) 2122-2131
23. Brinck U., Gabius H.J., Zeng F.Y., Gerke V., Lazarou D., Zografakis C., Tsambaos D., and Berger H. Differential expression of calcyclin and its accessible ligands in various types of cutaneous tumors. J. Dermatol. Sci. 10 (1995) 181-190
24. Vimalachandran D., Greenhalf W., Thompson C., Lüttges J., Prime W., Campbell F., Dodson A., Watson R., Crnogorac-Jurcevic T., Lemoine N., Neoptolemos J., and Costello E. High nuclear S100A6 (calcyclin) is significantly associated with poor survival in pancreatic cancer patients. Cancer Res. 65 (2005) 3218-3225
25. Ghezzo F., Lauret E., Ferrari S., and Baserga R. Growth factor regulation of the promoter for calcyclin, a growth-regulated gene. J. Biol. Chem. 263 (1988) 4758-4763
26. Tsoporis J.N., Izhar S., and Parker T.G. Expression of S100A6 in cardiac myocytes limits apoptosis induced by tumor necrosis factor-alpha. J. Biol. Chem. 283 (2008) 30174-30183
27. Tonini G.P., Casalaro A., Cara A., and Di Martino D. Inducible expression of calcyclin, a gene with strong homology to S-100 protein, during neuroblastoma cell differentiation and its prevalent expression in Schwann-like cell lines. Cancer Res. 51 (1991) 1733-1737
28. Hong E.J., Park S.H., Choi K.C., Leung P.C., and Jeung E.B. Identification of estrogen-regulated genes by microarray analysis of the uterus of immature rats exposed to endocrine disrupting chemicals. Reprod. Biol. Endocrinol. 4 (2006) 49-61
29. Busch A.K., Cordery D., Denyer G.S., and Biden T.J. Expression profiling of palmitate- and oleate-regulated genes provides novel insights into the effects of chronic lipid exposure on pancreatic beta-cell function. Diabetes 51 (2002) 977-987
30. Courtois-Coutry N., Le Moellic C., Boulkroun S., Fay M., Cluzeaud F., Escoubet B., Farman N., and Blot-Chabaud M. Calcyclin is an early vasopressin-induced gene in the renal collecting duct. Role in the long term regulation of ion transport. J. Biol. Chem. 277 (2002) 25728-25734
31. Kucharczak J., Pannequin J., Camby I., Decaestecker C., Kiss R., and Martinez J. Gastrin induces over-expression of genes involved in human U373 glioblastoma cell migration. Oncogene 20 (2001) 7021-7028
32. Lewington A.J., Padanilam B.J., and Hammerman M.R. Induction of calcyclin after ischemic injury to rat kidney. Am. J. Physiol. 273 (1997) F380-F385
33. Breen E.C., Fu Z., and Normand H. Calcyclin gene expression is increased by mechanical strain in fibroblasts and lung. Am. J. Respir. Cell Mol. Biol. 21 (1999) 746-752
34. Leśniak W., Szczepańska A., and Kuźnicki J. Calcyclin (S100A6) expression is stimulated by agents evoking oxidative stress via the antioxidant response element. Biochim. Biophys. Acta 1744 (2005) 29-37
35. Leśniak W., Jezierska A., and Kuźnicki J. Upstream stimulatory factor is involved in the regulation of the human calcyclin (S100A6) gene. Biochim. Biophys. Acta 1517 (2000) 73-81
36. Joo J.H., Kim J.W., Lee Y., Yoon S.Y., Kim J.H., Paik S.G., and Choe I.S. Involvement of NF-kappaB in the regulation of S100A6 gene expression in human hepatoblastoma cell line HepG2. Biochem. Biophys. Res. Commun. 307 (2003) 274-280
37. Króliczak W., Pietrzak M., and Puzianowska-Kuznicka M. P53-dependent suppression of the human calcyclin gene (S100A6): the role of Sp1 and of NfkappaB. Acta Biochim. Pol. 55 (2008) 559-570
38. Rehman I., Cross S.S., Catto J.W., Leiblich A., Mukherjee A., Azzouzi A.R., Leung H.Y., and Hamdy F.C. Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer. Prostate 65 (2005) 322-330
39. Leśniak W., Słomnicki Ł.P., and Kuźnicki J. Epigenetic control of the S100A6 (calcyclin) gene expression. J. Invest. Dermatol. 127 (2007) 2307-2314
40. Calabretta B., Kaczmarek L., Mars W., Ochoa D., Gibson C.W., Hirschhorn R.R., and Baserga R. Cell-cycle-specific genes differentially expressed in human leukemias. Proc. Natl. Acad. Sci. USA 82 (1985) 4463-4467
41. Murphy L.C., Murphy L.J., Tsuyuki D., Duckworth M.L., and Shiu R.P. Cloning and characterization of a cDNA encoding a highly conserved, putative calcium binding protein, identified by an anti-prolactin receptor antiserum. J. Biol. Chem. 263 (1988) 2397-2401
42. Guo X.J., Chambers A.F., Parfett C.L.J., Waterhouse P., Murphy L.C., Reid R.E., Craig A.M., Edwards D.R., and Denhardt D.T. Identification of a serum inducible messenger RNA (5B10) as the mouse homologue of calcyclin: tissue distribution and expression in metastatic, ras-transformed NIH 3T3 cells. Cell Growth Differ. 1 (1990) 333-338
43. Weterman M.A., Stoopen G.M., van Muijen G.N., Kuznicki J., Ruiter D.J., and Bloemers H.P. Expression of calcyclin in human melanoma cell lines correlates with metastatic behavior in nude mice. Cancer Res. 52 (1992) 1291-1296
44. Komatsu K., Andoh A., Ishiguro S., Suzuki N., Hunai H., Kobune-Fujiwara Y., Kameyama M., Miyoshi J., Akedo H., and Nakamura H. Increased expression of S100A6 (calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas. Clin. Cancer Res. 6 (2000) 172-177
45. Ohuchida K., Mizumoto K., Yu J., Yamaguchi H., Konomi H., Nagai E., Yamaguchi K., Tsuneyoshi M., and Tanaka M. S100A6 is increased in a stepwise manner during pancreatic carcinogenesis: clinical value of expression analysis in 98 pancreatic juice samples. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 649-654
46. Yang Y.Q., Zhang L.J., Dong H., Jiang C.L., Zhu Z.G., Wu J.X., Wu Y.L., Han J.S., Xiao H.S., Gao H.J., and Zhang Q.H. Upregulated expression of S100A6 in human gastric cancer. J. Dig. Dis. 8 (2007) 186-193
47. Kim J., Kim J., Yoon S., Joo J., Lee Y., Lee K., Chung J., and Choe I. S100A6 protein as a marker for differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma. Hepatol. Res. 23 (2002) 274-286
48. Melle C., Ernst G., Schimmel B., Bleul A., and von Eggeling F. Colon-derived liver metastasis, colorectal carcinoma, and hepatocellular carcinoma can be discriminated by the Ca(2+)-binding proteins S100A6 and S100A11. PLoS One 3 (2008) 3767-3775
49. Luu H.H., Zhou L., Haydon R.C., Deyrup A.T., Montag A.G., Huo D., Heck R., Heizmann C.W., Peabody T.D., Simon M.A., and He T.C. Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma. Cancer Lett. 229 (2005) 135-148
50. Kordowska J., Apel A., Brand I.A., and Kuznicki J. Distribution and level of calcyclin in normal rat tissues and in experimentally induced liver cirrhosis biliaris. Acta Histochem. Cytochem. 27 (1994) 205-218
51. Ju W., Eichinger F., Bitner M.., Oh J., McWeeney S., Berthier C.C., Shedden K., Cohen C.D., Hunger A., Trick S., Kopp J.B., Stoeckert Jr. C.J., Dikman S., Schröppel B., Thomas D.B., Schlondorff D., Tretzler M., and Ettinger E.P. Renal gene and protein expression signatures for prediction of kidney disease progression. Am. J. Pathol. 174 (2009) 2073-2085
52. Stanton L.W., Garrard L.J., Damm D., Garrick B.L., Lam A., Kapoun A.M., Zheng Q., Protter A.A., Schreiner G.F., and White R.T. Altered patterns of gene expression in response to myocardial infarction. Circ. Res. 86 (2000) 939-945
53. Boom A., Pochet R., Authelet M., Pradier L., Borghgraef P., Van Leuven F., Heizmann C.W., and Brion J.P. Astrocytic calcium/zinc binding protein S100A6 over expression in Alzheimer's disease and in PS1/APP transgenic mice models. Biochim. Biophys. Acta 1742 (2004) 161-168
54. Hoyaux D., Boom A., Van den Bosch L., Belot N., Martin J.J., Heizmann C.W., Kiss R., and Pochet R. S100A6 overexpression within astrocytes associated with impaired axons from both ALS mouse model and human patients. J. Neuropathol. Exp. Neurol. 61 (2002) 736-744
55. Hirschhorn R.R., Aller P., Yuan Z.A., Gibson C.W., and Baserga R. Cell-cycle-specific cDNAs from mammalian cells temperature sensitive for growth. Proc. Natl. Acad. Sci. USA 81 (1984) 6004-6008
56. Filipek A., and Kuźnicki J. Molecular cloning and expression of a mouse brain cDNA encoding a novel protein target of calcyclin. J. Neurochem. 70 (1998) 1793-1798
57. Matsuzawa S.I., and Reed J.C. Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol. Cell 7 (2001) 915-926
58. Nowotny M., Spiechowicz M., Jastrzebska B., Filipek A., Kitagawa K., and Kuznicki J. Calcium-regulated interaction of Sgt1 with S100A6 (calcyclin) and other S100 proteins. J. Biol. Chem. 278 (2003) 26923-26928
59. Filipek A., Michowski W., and Kuznicki J. Involvement of S100A6 (calcyclin) and its binding partners in intracellular signaling pathways. Adv. Enzyme Regul. 48 (2008) 225-239
60. Sbroggiò M., Ferretti R., Percivalle E., Gutkowska M., Zylicz A., Michowski W., Kuznicki J., Accornero F., Pacchioni B., Lanfranchi G., Hamm J., Turco E., Silengo L., Tarone G., and Brancaccio M. The mammalian CHORD-containing protein melusin is a stress response protein interacting with Hsp90 and Sgt1. FEBS Lett. 582 (2008) 1788-1794
61. Shimamoto S., Takata M., Tokuda M., Oohira F., Tokumitsu H., and Kobayashi R. Interactions of S100A2 and S100A6 with the tetratricopeptide repeat proteins, Hsp90/Hsp70-organizing protein and kinesin light chain. J. Biol. Chem. 283 (2008) 28246-28258
62. Spiechowicz M., Zylicz A., Bieganowski P., Kuznicki J., and Filipek A. Hsp70 is a new target of Sgt1 - an interaction modulated by S100A6. Biochem. Biophys. Res. Commun. 357 (2007) 1148-1153
63. Fernandez-Fernandez M.R., Rutherford T.J., and Fersht A.R. Members of the S100 family bind p53 in two distinct ways. Protein Sci. 17 (2008) 1663-1670
64. Słomnicki Ł.P., Nawrot B., and Leśniak W. S100A6 binds p53 and affects its activity. Int. J. Biochem. Cell Biol. 41 (2009) 784-790
65. van Dieck J., Fernandez-Fernandez M.R., Veprintsev D.B., and Fersht A.R. Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers. J. Biol. Chem. 284 (2009) 13804-13811
66. Breen E.C., and Tang K. Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro. J. Cell. Biochem. 88 (2003) 848-854
67. L.P. Słomnicki, W. Lesniak, S100A6 (calcyclin) induces senescence-like changes in cell cycle, morphology and functional characteristics of mouse NIH 3T3 fibroblasts, J. Cell. Biochem., in press.
68. 2+ ion-binding protein, contributes to the anabolic effects of simvastatin on bone. J. Biol. Chem. 279 (2004) 21239-21247
69. Ohuchida K., Mizumoto K., Ishikawa N., Fujii K., Konomi H., Nagai E., Yamaguchi K., Tsuneyoshi M., and Tanaka M. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target. Clin. Cancer Res. 11 (2005) 7785-7793
70. Luo X., Sharff K.A., Chen J., He T.C., and Luu H.H. S100A6 expression and function in human osteosarcoma. Clin. Orthop. Relat. Res. 466 (2008) 2060-2070
71. Cervera A.M., Apostolova N., Crespo F.L., Mata M., and McCreath K.J. Cells silenced for SDHB expression display characteristic features of the tumor phenotype. Cancer Res. 68 (2008) 4058-4067
72. Nedjadi T., Kitteringham N., Campbell F., Jenkins R.E., Park B.K., Navarro P., Ashcroft F., Tepikin A., Neoptolemos J.P., and Costello E. S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility. Br. J. Cancer 101 (2009) 1145-1154
73. Svasti J., Srisomsap C., Subhasitanont P., Keeratichamroen S., Chokchaichamnankit D., Ngiwsara L., Chimnoi N., Pisutjaroenpong S., Techasakul S., and Chen S.T. Proteomic profiling of cholangiocarcinoma cell line treated with pomiferin from Derris malaccensis. Proteomics 5 (2005) 4504-4509
74. Joo J.H., Yoon S.Y., Kim J.H., Paik S.G., Min S.R., Lim J.S., Choe I.S., Choi I., and Kim J.W. S100A6 (calcyclin) enhances the sensitivity to apoptosis via the upregulation of caspase-3 activity in Hep3B cells. J. Cell. Biochem. 103 (2008) 1183-1197
75. Leong S., Christopherson R.I., and Baxter R.C. Profiling of apoptotic changes in human breast cancer cells using SELDI-TOF mass spectrometry. Cell. Physiol. Biochem. 20 (2007) 579-590
76. Celis J.E., Crüger D., Kiil J., Dejgaard K., Lauridsen J.B., Ratz G.P., Basse B., Celis A., Rasmussen H.H., Bauw G., et al. A two-dimensional gel protein database of noncultured total normal human epidermal keratinocytes: identification of proteins strongly up-regulated in psoriatic epidermis. Electrophoresis 11 (1990) 242-254
77. Thordarson G., Southard J.N., and Talamantes F. Purification and characterization of mouse decidual calcyclin: a novel stimulator of mouse placental lactogen-II secretion. Endocrinology 129 (1991) 1257-1265
78. Okazaki K., Niki I., Iino S., Kobayashi S., and Hidaka H. A role of calcyclin, a Ca(2+)-binding protein, on the Ca(2+)-dependent insulin release from the pancreatic beta cell. J. Biol. Chem. 269 (1994) 6149-6152
79. Fujii T., Kuzumaki N., Ogoma Y., and Kondo Y. Effects of calcium-binding proteins on histamine release from permeabilized rat peritoneal mast cells. Biol. Pharm. Bull. 17 (1994) 581-585
80. Leclerc E., Fritz G., Weibel M., Heizmann C.W., and Galichet A. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J. Biol. Chem. 282 (2007) 31317-31331